Current issues in hyperparathyroidism

Otolaryngologic Clinics of North America

Volumn 36, Issue 1, 2003, Pages 207-215

  Krempl, Greg A ^a   Medina, Jesus E ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PATIENT REFERRAL; PREOPERATIVE EVALUATION; REVIEW; SURGICAL ANATOMY; TISSUE DISTRIBUTION; TREATMENT INDICATION; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

ADENOMA; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PREOPERATIVE CARE; REFERRAL AND CONSULTATION; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 0037301904     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(02)00154-8     Document Type: Review

References (33)

1. Silverberg SJ, Bilezikian JP, Bone HG, et al. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab 1999;84(7):2275-85.
2. Sivula A, Ronni-Sivula H. Natural history of treated primary hyperparathyroidism. Surg Clin North Am 1987;67(2):329-41.
3. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364-7.
4. Anonymous. NIH Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991; 114(7):593-7.
5. Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;341(17):1249-55.
6. Wermers RA, Khosla S, Atkinson EJ, et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 1998;104(2):115-22.
7. Grey AB, Stapleton JP, Evans MC, et al. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 1996;125(5):360-8.
8. Irvin GL, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA 2000;284(8):934-6.
9. Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 1998;186(3):293-305.
10. Purcell GP, Dirbas FM, Brooke JR, Lane MJ, Desser T, McDougall IR, et al. Parathyroid localization with high-resolution ultrasound and technetium Tc99m sestamibi. Arch Surg 1999;134(8):824-30.
11. Mitchell BK, Merrell RC, Kinder BK. Localization studies in patients with hyperparathyroidism. Surg Clin North Am 1995;75(3):483-98.
12. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 1998;104:1121-7.
13. Regal M, Paramo C, Luna CR, Perez Mendez LF, Sierra JM, Rodriguez I, et al. Coexistence of primary hyperparathyroidism and thyroid disease. J Endocrinol Invest 1999;22(3):191-7.
14. Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S, et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997;24(2):143-9.
15. Bonjer HJ, Bruining HA, Valkema R, Lameris JS, de Herder WW, van der Harst E, Pols HA. Single radionuclide scintigraphy with 99mtechnetium-sestamibi and ultrasonography in hyperparathyroidism. Eur J Surg 1997;163(1):27-32.
16. Fjeld JG, Erichsen K, Pfeffer PF, Clausen OP, Rootwelt K. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi [see comments]. J Nucl Med 1997 June;38(6):831-4. Comments in: J Nucl Med 1997;38(6):840-1, J Nucl Med 1998 Jul;39(7):1306.
17. Neumann DR, Esselstyn CB Jr, Go RT, Wong CO, Rice TW, Obuchowski NA. Comparison of double-phase 99mTc-sestamibi with 1231-99mTc-sestamibi subtraction SPECT in: hyperparathyroidism. AJR 1997;169(6):1671-4.
18. Bergenfelz A, Tennvall J, Valdermarsson S, Lindlom P, Tibblin S. Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients: with predominately mild primary hyperparathyroidism. Surg 1997;121(6):601-5.
19. Hindie E, Melliere D, Perlemuter L, Jeanguillaume C, Galle P. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning. Radiology 1997;204(1):221-8.
20. Sinha CK, Hamaker R, Hamaker RC, Freeman SB, Borrowdale FW, Huntley TC. Utility of preoperative redionuclide scanning for primary hyperparathyroidism. Laryngoscope 1997;107(6):753-8.
21. Caixas A, Berna L, Hernandez A, Tebar FJ, et al. Efficacy of preoperative diagnosis imaging of technetium 99m sestamibi scintigraphy. Surgery 1997;121:535-41.
22. Carter WB, Sarfati MR, Fox KA, Patton DD. Preoperative detection of sporadic parathyroid adenomas using technetium-99m-sestamibi: What role in clinical practice? Southeastern Surgical Congress. April 1997. Abstracts Vol 63(4).
23. Shen W, Sabanci U, Morita ET, Siperstein AE, et al. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 1997;132(9):969-74; discussion 974-6.
24. Pattou F, Huglo D, Proye C. Radionuclide scanning in parathyroid diseases. Br J Surg 1998;85(12):1605-16.
25. Hindie E, Melliere D, Jeanguillaume C, Perlemuter L, Chehade F, Galle P. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med 1998;39(6):1100-5.
26. Kountakis SE, Maillard AJ. Parathyroid adenomas: Is bilateral neck exploration necessary? Am J Otolaryngol 1999;20(6):396-9.
27. Catargi B, Raymond JM, Lafarge-Gense V, Leccia F, Roger P, Tabarin A. Localization of parathyroid tumors using endoscopic ultrasonography in primary hyperparathyroidism. J Endocrinol Invest 1999;22(9):688-92.
28. Lumachi F, Zucchetta P, Marzola MC, Boccagni P, Angelini F, Bui F, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000;143(6):755-60.
29. Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTc04/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001;28(9):1351-9.
30. Jones JM, Russell CF, Ferguson WR, Laird JD. Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients. Clin Radiol 2001;56(7):556-9.
31. Arici C, Cheah WK, Ituarte PH, Morita E, Lynch TC, Siperstein AE, et al. Can localization studies be used to direct focused parathyroid operations? Surgery 2001; 129(6):720-9.
32. Kim CK, Kim S, Krynyckyi BR, Machac J, Inabnet WB. The efficacy of sestamibi parathyroid scintigraphy for directing surgical approaches based on modified interpretation criteria. Clin Nucl Med 2002;27(4):246-8.
33. Perrier ND, Ituarte PH, Morita E, Hamill T, Gielow R, Duh QY, et al. Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 2002;87(3):1024-9.